In addition, ROC curve analyzes revealed that ADAM17 and ATG3 showed high clinical performance (AUC = 0.989 and AUC = 0.956, respectively), reinforcing that EVs enriched by the proteins may represent valuable biomarkers in B-ALL (63). The gene discussed is ADAM17; the disease is precursor B-cell acute lymphoblastic leukemia.